September 10, 2014 - Laboratory Practices Committee Revises Ebola Guidance Document
After consultation with CDC Personnel, the PSAB Committee on Laboratory Practices has revised the “Interim Laboratory Guidelines for Handling/Testing Specimens from Cases or Suspected Cases of Hemorrhagic Fever Virus (HFV)”. The guideline was prepared to assist laboratory personnel with testing in accordance with the current CDC Ebola Interim Guidance.
The ASM sent an e-mail to ASM members regarding US Government communications about ensuring biosafety in US laboratories. The e-mail includes links to a White House memo and an NIH advisory.
The National Institutes of Health (NIH) announces National Biosafety Stewardship Month
The March issue of the e-Public Policy Update has been published by the Office of Public Affairs.
ASM sent a statement out to ASM members reminding them to practice safe "laboratory housekeeping."
ASM commented on an FDA proposal to reclassify antigen based rapid influenza virus antigen detection test systems intended to detect influenza virus directly from clinical specimens.
The ASM sent a statement to ASM members on Dual Use Research of Concern and Biosafety.
The ASM sent the following statement to ASM members regarding the recent biosafety lapses.
The ASM sent a letter to Senator Tom Harkin thanking him for the Accelerating Biomedical Research Act and his leadership regarding funding for the National Institutes of Health.
ASM provided comments to the Centers for Medicare & Medicaid Services (CMS) regarding Section 1834A, “Improving Policies for Clinical Diagnostic Laboratory Tests,” added to the Social Security Law by the Protecting Access to Medicare Act of 2014 (PAMA).